These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29325867)

  • 21. Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study.
    Smith RC; Maayan L; Wu R; Youssef M; Jing Z; Sershen H; Szabo V; Meyers J; Jin H; Zhao J; Davis JM
    Psychopharmacology (Berl); 2018 Dec; 235(12):3545-3558. PubMed ID: 30382354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model.
    Chintoh AF; Mann SW; Lam L; Giacca A; Fletcher P; Nobrega J; Remington G
    Schizophr Res; 2009 Mar; 108(1-3):127-33. PubMed ID: 19157785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weight gain with atypical antipsychotics: evidence and insights.
    Henderson DC
    J Clin Psychiatry; 2007; 68 Suppl 12():18-26. PubMed ID: 17956152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism.
    Melkersson KI; Dahl ML; Hulting AL
    Psychopharmacology (Berl); 2004 Aug; 175(1):1-6. PubMed ID: 15221198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of Topiramate for atypical antipsychotic-induced body weight gain and metabolic adversities: a systematic review and meta-analysis].
    Liang H; Li H; Hu Y; Li S; Lü L; Song X
    Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(3):216-23. PubMed ID: 26879726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The implications of weight changes with antipsychotic treatment.
    Sussman N
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities.
    Ruedrich SL; Swales TP; Rossvanes C; Diana L; Arkadiev V; Lim K
    J Intellect Disabil Res; 2008 Feb; 52(Pt 2):132-40. PubMed ID: 18197952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical antipsychotics and weight gain.
    Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):46-58. PubMed ID: 19667655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential metabolic effects of antipsychotic treatments.
    Haupt DW
    Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S149-55. PubMed ID: 16872808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
    de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
    J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of metformin to limit weight-gain with atypical antipsychotics.
    Lee YJ; Jeong JH
    J Clin Pharm Ther; 2011 Oct; 36(5):537-45. PubMed ID: 21418264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of atypical antipsychotic medications in individuals with anorexia nervosa: a systematic review and meta-analysis.
    Lebow J; Sim LA; Erwin PJ; Murad MH
    Int J Eat Disord; 2013 May; 46(4):332-9. PubMed ID: 23001863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute hyperglycemia associated with short-term use of atypical antipsychotic medications.
    Liao TV; Phan SV
    Drugs; 2014 Feb; 74(2):183-94. PubMed ID: 24399515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Antidiabetic and Antilipidemic Medications in Children and Adolescents Treated With Atypical Antipsychotics in a Virginia Medicaid Population.
    Varghese D; Kirkwood CK; Carroll NV
    Ann Pharmacother; 2016 Jun; 50(6):463-70. PubMed ID: 27009289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of antipsychotic medications on appetite, weight, and insulin resistance.
    Deng C
    Endocrinol Metab Clin North Am; 2013 Sep; 42(3):545-63. PubMed ID: 24011886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study.
    Gebhardt S; Theisen FM; Haberhausen M; Heinzel-Gutenbrunner M; Wehmeier PM; Krieg JC; Kühnau W; Schmidtke J; Remschmidt H; Hebebrand J
    J Clin Pharm Ther; 2010 Apr; 35(2):207-11. PubMed ID: 20456740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of atypical antipsychotics on weight and serum lipid levels.
    Meyer JM
    J Clin Psychiatry; 2001; 62 Suppl 27():27-34; discussion 40-1. PubMed ID: 11806486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
    Silvestre JS; Prous J
    Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.
    Zhang JP; Lencz T; Zhang RX; Nitta M; Maayan L; John M; Robinson DG; Fleischhacker WW; Kahn RS; Ophoff RA; Kane JM; Malhotra AK; Correll CU
    Schizophr Bull; 2016 Nov; 42(6):1418-1437. PubMed ID: 27217270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.